$Conduit Pharmaceuticals (CDT.US)$ Conduit Pharmaceuticals has announced a sales agreement with A.G.P./Alliance Global Partners to offer and sell shares of common stock with an aggregate offering price of up to $3,556,586. The sales may occur from time to time through A.G.P., acting as the sales agent or principal. Conduit Pharmaceuticals, an emerging growth company listed under the symbol 'CDT' on the Nasdaq Global Market, plans to use the initial proceeds to repay approximately $600,000 in prin...

$Conduit Pharmaceuticals (CDT.US)$
02/11/2024 - 04:45
SAN DIEGO and LONDON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced the restructuring of a portion of its financial obligations, enhancing its balance sheet and liquidity. The Company has restructured the $2.65 million loan note with Nirland Limited (“Nirland”) and secured $1.2 million in new pr...